Literature DB >> 25604144

Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.

Dong-Liang Cheng1, Yuan-Yuan Xiang, Li-juan Ji, Xiao-Jie Lu.   

Abstract

Competing endogenous RNAs (ceRNAs) refer to RNA transcripts, such as mRNAs, non-coding RNAs, pseudogene transcripts, and circular RNAs, that can regulate each other by competing for the same pool of miRNAs. ceRNAs involve in the pathogenesis of several common cancers such as prostate cancer, liver cancer, breast cancer, lung cancer, gastric cancer, endometrial cancer, and so on. ceRNA activity is determined by factors such as miRNA/ceRNA abundance, ceRNAs binding affinity to miRNAs, RNA editing, and RNA-binding proteins. The alteration of any of these factors may lead to ceRNA network imbalance and thus contribute to cancer initiation and progression. There are generally three steps in ceRNA research conductions: ceRNA prediction, ceRNA validation, and ceRNA functional investigation. Deciphering ceRNA interplay in cancer provides new insight into cancer pathogenesis and opportunities for therapy exploration. In this review, we try to give readers a concise and reliable illustration on the mechanism, functions, research approaches, and perspective of ceRNA in cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25604144     DOI: 10.1007/s13277-015-3093-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  72 in total

1.  Molecular biology: RNA lost in translation.

Authors:  David Tollervey
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

2.  Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.

Authors:  Xi Zhou; Qin Gao; Jianzhong Wang; Xin Zhang; Kaige Liu; Zhao Duan
Journal:  Gynecol Oncol       Date:  2014-02-28       Impact factor: 5.482

3.  Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments.

Authors:  Ugo Ala; Florian A Karreth; Carla Bosia; Andrea Pagnani; Riccardo Taulli; Valentine Léopold; Yvonne Tay; Paolo Provero; Riccardo Zecchina; Pier Paolo Pandolfi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

4.  TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Authors:  Kyung Park; James T Dalton; Ramesh Narayanan; Christopher E Barbieri; Michael L Hancock; David G Bostwick; Mitchell S Steiner; Mark A Rubin
Journal:  J Clin Oncol       Date:  2013-12-02       Impact factor: 44.544

5.  Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.

Authors:  Gan Yu; Weimin Yao; Kiranmai Gumireddy; Anping Li; Ji Wang; Wei Xiao; Ke Chen; Haibing Xiao; Heng Li; Kun Tang; Zhangqun Ye; Qihong Huang; Hua Xu
Journal:  Mol Cancer Ther       Date:  2014-09-23       Impact factor: 6.261

6.  Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells.

Authors:  Yuchen Liu; Hongzhou Cui; Wenjun Wang; Longnian Li; Zaixing Wang; Sen Yang; Xuejun Zhang
Journal:  Int J Biochem Cell Biol       Date:  2013-09-11       Impact factor: 5.085

7.  microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.

Authors:  Nirmalya Dey; Falguni Das; Nandini Ghosh-Choudhury; Chandi Charan Mandal; Dipen J Parekh; Karen Block; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

8.  Transcriptome-wide analysis of UTRs in non-small cell lung cancer reveals cancer-related genes with SNV-induced changes on RNA secondary structure and miRNA target sites.

Authors:  Radhakrishnan Sabarinathan; Anne Wenzel; Peter Novotny; Xiaojia Tang; Krishna R Kalari; Jan Gorodkin
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.

Authors:  Guangxian Xu; Yilin Zhang; Jun Wei; Wei Jia; Zhaohui Ge; Zhaobo Zhang; Xiaoming Liu
Journal:  BMC Cancer       Date:  2013-10-10       Impact factor: 4.430

10.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

View more
  55 in total

Review 1.  Circular RNAs function as ceRNAs to regulate and control human cancer progression.

Authors:  Yaxian Zhong; Yajun Du; Xue Yang; Yongzhen Mo; Chunmei Fan; Fang Xiong; Daixi Ren; Xin Ye; Chunwei Li; Yumin Wang; Fang Wei; Can Guo; Xu Wu; Xiaoling Li; Yong Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2018-04-07       Impact factor: 27.401

2.  MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells.

Authors:  Jianguo Hu; Ying Meng; Zhanqin Zhang; Qiuting Yan; Xingwei Jiang; Zilan Lv; Lina Hu
Journal:  Autophagy       Date:  2016-11-22       Impact factor: 16.016

3.  An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway.

Authors:  Mo Wang; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yixue Xue; Xuelei Ruan; Shuyuan Shen; Di Wang; Zhen Li; Heng Cai; Yunhui Liu
Journal:  J Cell Mol Med       Date:  2020-05-05       Impact factor: 5.310

Review 4.  Roles of long noncoding RNAs in gastric cancer and their clinical applications.

Authors:  Weiliang Sun; Yunben Yang; Chunjing Xu; Yi Xie; Junming Guo
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-31       Impact factor: 4.553

Review 5.  Endogenous microRNA sponges: evidence and controversy.

Authors:  Daniel W Thomson; Marcel E Dinger
Journal:  Nat Rev Genet       Date:  2016-04-04       Impact factor: 53.242

6.  Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.

Authors:  Jingli Sun; Shaofeng Gao; Cuihua Lu
Journal:  Mol Cell Biochem       Date:  2019-06-03       Impact factor: 3.396

7.  Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.

Authors:  Wenhao Weng; Qing Wei; Shusuke Toden; Kazuhiro Yoshida; Takeshi Nagasaka; Toshiyoshi Fujiwara; Sanjun Cai; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Clin Cancer Res       Date:  2017-02-07       Impact factor: 12.531

8.  Network analysis of pseudogene-gene relationships: from pseudogene evolution to their functional potentials.

Authors:  Travis S Johnson; Sihong Li; Jonathan R Kho; Kun Huang; Yan Zhang
Journal:  Pac Symp Biocomput       Date:  2018

Review 9.  Circular RNA participates in the carcinogenesis and the malignant behavior of cancer.

Authors:  Zhen-Jun Zhao; Jun Shen
Journal:  RNA Biol       Date:  2015-12-09       Impact factor: 4.652

Review 10.  Circular RNAs as potential biomarkers for cancer diagnosis and therapy.

Authors:  Fengling Wang; Adil J Nazarali; Shaoping Ji
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.